Pacira BioSciences Notified of Abbreviated New Drug Application Filing
Pacira BioSciences, Inc. (Nasdaq: PCRX), a leader in non-opioid pai…
Assessing the "No Kings" Protest in Salt Lake City
The second "No Kings" protest in Salt Lake City has concluded, and organizers are refle…
Neumora Therapeutics Initiates Phase 1 Clinical Study of NMRA-898
Neumora Therapeutics, Inc. announced the initiation of a Phase 1 single-…
Potential Human Pandemic from H9N2 Bird Flu Strain
A team of scientists has found that the H9N2 bird flu virus, often considered minor, ha…
Designing Light-Filled Living Spaces
In Florida, natural light is one of the state’s most abundant resources—and homeowners are increasing…
IMA PHARMA & IMA MED-TECH at CPHI Frankfurt 2025
IMA will showcase its pharmaceutical and medical industry solutions at CPHI Worldwide 202…
Ericsson, Nokia Collaborate on 6G Video Research
Nokia, Ericsson, and the Fraunhofer Heinrich Hertz Institute have presented a proof-of-co…
Tension at McLaren
Lando Norris had priority over Oscar Piastri for a pitstop in Singapore, but this decision may have given an advantage …
Utah's Olympic Organizers in NYC
Leaders of Utah's 2034 Winter Games are attending the U.S. Olympic and Paralympic Committee Team USA Medi…
Kymera Therapeutics Presents New Preclinical Data for KT-579
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, announ…